Links

Homepage

Stock List

Search by Ticker

News

Login

Meridian Bioscience Inc. (NASDAQ:VIVO)
Stock Analysis

VIVO19.32
▼ -20.46%-4.97

Stock Analysis

The following stock analysis is based on 7.7 years of data (i.e. since Nov 12, 2012). All the stock history has been downloaded.

Stock Exchange

Meridian Bioscience Inc. trades on the NasdaqGS exchange in USD dollars.

Sector

It is in the healthcare sector.

Current Status of Meridian Bioscience Inc.

It is currently trading at $19.32 ($24.29 the previous day).

Financials

The next reporting date is in 88 days (2020 11 05).

CNN estimates profits for the upcoming quarter will be $0.20 per share ($64.8M). The current Canada / US exchange rate is 1.3382.



Over the past 12 months, $569065 worth of shares have been purchased and $0 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 0.9% per year assuming steady exponential growth. The actual 5 year average is -7.9. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year11.655046644295-22.7- Below Average
2 year15.0836580086581.8+ Above Average
3 year14.814831932773-4.8+ Above Average
4 year15.554798387097-19.5- Below Average
5 year19.3180754716985.7+ Above Average
Meridian Bioscience Inc. is projected by analysts to get to $26.50 within the next 12 months (37.2%), but preticted targets range from as high as $34.00 (76%) and as low as $19(-1.7%).

Risk

The worst drop it has had in recent years is -85.5%. It has a up and down shape to the stock curve, which means the stock can have significant gains followed by losses. Good for day trading, but needs to be watched if held for any significant amount of time.

Stock shape test

DAYS AG0PRICE
1024.71DROPPING
3024.37RISING
6015.795RISING
1507.67RISING
36511.05DROPPING
80014.8DROPPING
120014.2RISING
160019.82DROPPING
200019.15RISING


With an average increase of 0.9% year over year, if Meridian Bioscience Inc. is bought at the worst time, Stockmarketizer analysts estimate it will take 1140 months before the stock will recover to the original purchase price. The P/E value is 18.92. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Tradingview BuySell Widget

Yahoo News Feed

Meridian Bioscience (VIVO) Beats Q3 Earnings and Revenue Estimates

Fri, 07 Aug 2020 13:05:01 Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 129.17% and 28.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

Are Institutions Heavily Invested In Meridian Bioscience, Inc.and's (NASDAQ:VIVO) Shares?

Fri, 07 Aug 2020 12:52:54 A look at the shareholders of Meridian Bioscience, Inc. (NASDAQ:VIVO) can tell us which group is most powerful...... Read Full Article

Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance

Fri, 07 Aug 2020 11:30:00 CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third quarter ended June 30, 2020. Third Quarter Fiscal 2020 Highlights: * Consolidated Net Revenue of $84.8 million, up 75% year-over-year * Life Science segment delivers record revenue of $63.2 million, ...... Read Full Article

Earnings Outlook for Meridian Bioscience

Thu, 06 Aug 2020 20:00:51 On Friday, August 07, Meridian Bioscience (NASDAQ: VIVO) will release its latest earnings report. Check out Benzingaand's preview to understand the implications.Earnings and Revenue Based on Meridian Bioscience management projections, analysts predict EPS of $0.25 on revenue of $66.04 million. In the ...... Read Full Article

Whatand's in Store for Meridian Bioscienceand's (VIVO) Q3 Earnings?

Wed, 05 Aug 2020 13:42:01 Meridian Bioscienceand's (VIVO) fiscal third-quarter results are likely to reflect strong performance by Life Science business line.... Read Full Article

Meridian Bioscience (VIVO) Stock Sinks As Market Gains: What You Should Know

Fri, 31 Jul 2020 21:45:09 Meridian Bioscience (VIVO) closed at $24.49 in the latest trading session, marking a -1.84% move from the prior day.... Read Full Article

Meridian Bioscience (VIVO) Earnings Expected to Grow: What to Know Ahead of Next Weekand's Release

Fri, 31 Jul 2020 16:30:04 Meridian Bioscience (VIVO) doesnand't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article

Did Hedge Funds Make The Right Call On Meridian Bioscience, Inc. (VIVO) ?

Tue, 28 Jul 2020 14:24:42 We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional ...... Read Full Article

Meridian Bioscience Announces New Board Member - Anthony Bihl

Tue, 28 Jul 2020 13:00:00 CINCINNATI, July 28, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately. “We welcome Tony to the board as a new independent director and look forward to the ...... Read Full Article

Benzingaand's Top Upgrades, Downgrades For July 27, 2020

Mon, 27 Jul 2020 13:33:04 Upgrades * For First Community Corp (NASDAQ: FCCO), Raymond James upgraded the previous rating of Market Perform to the current rating Outperform. In the second quarter, First Community showed an EPS of $0.30, compared to $0.37 from the year-ago quarter. At the moment, ...... Read Full Article

Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020

Thu, 16 Jul 2020 13:00:10 CINCINNATI, July 16, 2020 -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter 2020.... Read Full Article

Is Meridian Bioscience (NASDAQ:VIVO) Using Too Much Debt?

Mon, 13 Jul 2020 17:57:55 The external fund manager backed by Berkshire Hathawayand's Charlie Munger, Li Lu, makes no bones about it when he says...... Read Full Article

Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays

Mon, 13 Jul 2020 17:00:10 CINCINNATI, July 13, 2020 -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that.... Read Full Article

Is Meridian Bioscience (VIVO) Stock Outpacing Its Medical Peers This Year?

Fri, 10 Jul 2020 15:30:03 Is (VIVO) Outperforming Other Medical Stocks This Year?... Read Full Article

The Zacks Analyst Blog Highlights: Galiano Gold, Fortinet, Meridian Bioscience, Crescent Capital BDC and NextEra Energy

Wed, 01 Jul 2020 13:37:01 The Zacks Analyst Blog Highlights: Galiano Gold, Fortinet, Meridian Bioscience, Crescent Capital BDC and NextEra Energy... Read Full Article

Zacks.com featured highlights include: eXp World, Lakeland Industries, Meridian Bioscience, Kiniksa Pharmaceuticals and iClick Interactive Asia Group

Tue, 30 Jun 2020 13:56:01 Zacks.com featured highlights include: eXp World, Lakeland Industries, Meridian Bioscience, Kiniksa Pharmaceuticals and iClick Interactive Asia Group... Read Full Article

5 Stocks With Recent Price Strength Amid Spike in Coronavirus

Mon, 29 Jun 2020 12:09:12 Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.... Read Full Article

New Strong Buy Stocks for June 24th

Wed, 24 Jun 2020 15:18:03 New Strong Buy Stocks for June 24th... Read Full Article

Hedge Funds Have Never Been This Bullish On Meridian Bioscience, Inc. (VIVO)

Mon, 22 Jun 2020 15:59:23 Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge fundsand' and successful investorsand' positions as of the end of the ...... Read Full Article

Meridian Bioscience (VIVO) Soars to 52-Week High, Time to Cash Out?

Thu, 18 Jun 2020 13:15:01 Meridian Bioscience (VIVO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the companyand's fundamentals for clues.... Read Full Article
<